Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$618M |
| 2 |
Vale
VALE
|
+$332M |
| 3 |
CELG
Celgene Corp
CELG
|
+$309M |
| 4 |
CME Group
CME
|
+$306M |
| 5 |
Amazon
AMZN
|
+$290M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$435M |
| 2 |
Meta Platforms (Facebook)
META
|
+$342M |
| 3 |
Crown Castle
CCI
|
+$244M |
| 4 |
SLB Ltd
SLB
|
+$229M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.17% |
| 2 | Technology | 14.41% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Financials | 10.51% |
| 5 | Real Estate | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Midland States Bancorp
MSBI
$699M
| $582K | ﹤0.01% |
+24,200
| New | +$586K |
|
2877
ImmuCell
ICCC
$101M
| $580K | ﹤0.01% |
91,306
-500
| -0.5% | -$3.57K |
|
2878
Silicom
SILC
$229M
| $578K | ﹤0.01% |
15,100
-3,100
| -17% | -$112K |
|
|
MFNC
2879
DELISTED
Mackinac Financial Corporation
MFNC
| $578K | ﹤0.01% |
36,700
+2,584
| +8% | +$39.7K |
|
2880
iShares Russell 2000 Value ETF
IWN
$14.3B
| $576K | ﹤0.01% |
+4,800
| New | +$573K |
|
|
SFS
2881
DELISTED
Smart & Final Stores, Inc.
SFS
| $575K | ﹤0.01% |
+116,300
| New | +$705K |
|
2882
CB Financial Services
CBFV
$186M
| $574K | ﹤0.01% |
24,200
+5,700
| +31% | +$142K |
|
2883
Good Times Restaurants
GTIM
$14.6M
| $573K | ﹤0.01% |
236,810
-10,509
| -4% | -$26.7K |
|
|
FBMS
2884
DELISTED
The First Bancshares, Inc.
FBMS
| $572K | ﹤0.01% |
18,500
+4,300
| +30% | +$136K |
|
|
SPLP
2885
DELISTED
STEEL PARTNERS HOLDINGS L.P.
SPLP
| $571K | ﹤0.01% |
41,300
+12,857
| +45% | +$179K |
|
2886
Merit Medical Systems
MMSI
$5.08B
| $570K | ﹤0.01% |
+9,212
| New | +$523K |
|
|
BGMS
2887
Bio Green Med Solution Inc
BGMS
$4.91M
| $565K | ﹤0.01% |
8
+5
| +167% | +$291K |
|
2888
e.l.f. Beauty
ELF
$4.89B
| $565K | ﹤0.01% |
+53,287
| New | +$475K |
|
2889
Cartesian Therapeutics
RNAC
$229M
| $563K | ﹤0.01% |
7,923
+4,200
| +113% | +$266K |
|
2890
Invesco S&P 500 Low Volatility ETF
SPLV
$7.12B
| $563K | ﹤0.01% |
10,700
-35,200
| -77% | -$1.76M |
|
2891
Inspired Entertainment
INSE
$184M
| $561K | ﹤0.01% |
84,100
+31,100
| +59% | +$203K |
|
2892
Independent Bank
INDB
$3.99B
| $559K | ﹤0.01% |
6,900
-2,100
| -23% | -$166K |
|
|
CATC
2893
DELISTED
CAMBRIDGE BANCORP
CATC
| $555K | ﹤0.01% |
6,700
+1,100
| +20% | +$87.8K |
|
|
PRPH
2894
DELISTED
ProPhase Labs
PRPH
| $551K | ﹤0.01% |
18,320
+620
| +4% | +$19.1K |
|
|
SISI
2895
DELISTED
Shineco
SISI
| $543K | ﹤0.01% |
4
+1
| +33% | +$70.9K |
|
2896
Westlake Chemical Partners
WLKP
$763M
| $543K | ﹤0.01% |
+23,916
| New | +$545K |
|
|
BEDU
2897
DELISTED
Bright Scholar Education Holdings
BEDU
| $540K | ﹤0.01% |
13,050
-4,800
| -27% | -$206K |
|
|
LITB
2898
LightInTheBox
LITB
$58M
| $540K | ﹤0.01% |
66,658
+2,225
| +3% | +$11.8K |
|
|
SFIX
2899
Stitch Fix
SFIX
$536M
| $539K | ﹤0.01% |
19,100
-882,300
| -98% | -$21.9M |
|
|
IMDX
2900
Insight Molecular Diagnostics
IMDX
$150M
| $538K | ﹤0.01% |
+6,810
| New | +$439K |
|
Similar funds
Renaissance Technologies's Q1 2019 Portfolio in Review
As of Q1 2019, Renaissance Technologies held 3,883 positions worth $110B, up 20% from $91.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Renaissance Technologies deployed $7.09B of net new capital in Q1 2019, opening 532 new positions and adding to 1,751 existing holdings. Its largest new stake was Amazon: 3,483,100 shares worth $310M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $342M trimmed.
- Renaissance Technologies's largest Q1 2019 buy was Amazon: 3,483,100 shares worth $310M.
- Renaissance Technologies added most to Starbucks in Q1 2019, an estimated $618M increase.
- Renaissance Technologies's biggest Q1 2019 reduction was Meta Platforms (Facebook), cutting an estimated $342M.
- Renaissance Technologies fully exited Apple in Q1 2019, selling an estimated $435M.
- Renaissance Technologies's ten largest holdings make up 8.7% of its $110B portfolio in Q1 2019.
- Renaissance Technologies opened 532 new positions and closed 465 in Q1 2019.
- Renaissance Technologies's portfolio value rose 20% quarter-over-quarter to $110B.
Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.